company background image
002390 logo

Guizhou Xinbang Pharmaceutical XSEC:002390 Stock Report

Last Price

CN¥3.93

Market Cap

CN¥7.5b

7D

0%

1Y

-1.0%

Updated

06 Feb, 2025

Data

Company Financials

Guizhou Xinbang Pharmaceutical Co., Ltd.

XSEC:002390 Stock Report

Market Cap: CN¥7.5b

002390 Stock Overview

Researches, develops, manufactures, and sells Chinese herbal medicines and other pharmaceutical products in China and internationally. More details

002390 fundamental analysis
Snowflake Score
Valuation0/6
Future Growth0/6
Past Performance2/6
Financial Health6/6
Dividends4/6

Rewards

Price-To-Earnings ratio (34.3x) is below the CN market (34.9x)

Risk Analysis

Unstable dividend track record


My Notes

Capture your thoughts, links and company narrative

Guizhou Xinbang Pharmaceutical Co., Ltd. Competitors

Zhejiang Garden BiopharmaceuticalLtd

SZSE:300401

CN¥7.8b

Northeast Pharmaceutical Group

SZSE:000597

CN¥7.3b

Renhe PharmacyLtd

SZSE:000650

CN¥7.8b

Changzhou Qianhong BiopharmaLTD

SZSE:002550

CN¥7.2b

Price History & Performance

Summary of share price highs, lows and changes for Guizhou Xinbang Pharmaceutical
Historical stock prices
Current Share PriceCN¥3.93
52 Week HighCN¥4.85
52 Week LowCN¥2.86
Beta0.52
1 Month Change-8.18%
3 Month Change4.80%
1 Year Change-1.01%
3 Year Change-32.94%
5 Year Change-29.70%
Change since IPO-60.97%

Recent News & Updates

Recent updates

Shareholder Returns

002390CN PharmaceuticalsCN Market
7D0%0.009%0.02%
1Y-1.0%4.5%18.1%

Return vs Industry: 002390 underperformed the CN Pharmaceuticals industry which returned 4.5% over the past year.

Return vs Market: 002390 underperformed the CN Market which returned 18.1% over the past year.

Price Volatility

Is 002390's price volatile compared to industry and market?
002390 volatility
002390 Average Weekly Movement8.5%
Pharmaceuticals Industry Average Movement5.3%
Market Average Movement6.6%
10% most volatile stocks in CN Market10.7%
10% least volatile stocks in CN Market3.9%

Stable Share Price: 002390 has not had significant price volatility in the past 3 months compared to the CN market.

Volatility Over Time: 002390's weekly volatility (8%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
19955,149Lingzhong Kongwww.xinbang.com

Guizhou Xinbang Pharmaceutical Co., Ltd. researches, develops, manufactures, and sells Chinese herbal medicines and other pharmaceutical products in China and internationally. The company offers cardiovascular and cerebrovascular, digestive system, endocrine, tumor and immune regulation, blood system, rheumatism and rheumatoid, urinary system, antipyretic analgesic, cold medicine, gynecological treatment, and anti-infective drugs. It also operates in medical services; and pharmaceutical circulation business.

Guizhou Xinbang Pharmaceutical Co., Ltd. Fundamentals Summary

How do Guizhou Xinbang Pharmaceutical's earnings and revenue compare to its market cap?
002390 fundamental statistics
Market capCN¥7.45b
Earnings (TTM)CN¥217.25m
Revenue (TTM)CN¥6.20b

34.3x

P/E Ratio

1.2x

P/S Ratio

Is 002390 overvalued?

See Fair Value and valuation analysis

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
002390 income statement (TTM)
RevenueCN¥6.20b
Cost of RevenueCN¥5.10b
Gross ProfitCN¥1.10b
Other ExpensesCN¥882.31m
EarningsCN¥217.25m

Last Reported Earnings

Sep 30, 2024

Next Earnings Date

Apr 15, 2025

Earnings per share (EPS)0.11
Gross Margin17.73%
Net Profit Margin3.50%
Debt/Equity Ratio8.6%

How did 002390 perform over the long term?

See historical performance and comparison

Dividends

1.5%

Current Dividend Yield

78%

Payout Ratio

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/02/06 19:25
End of Day Share Price 2025/02/06 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Guizhou Xinbang Pharmaceutical Co., Ltd. is covered by 11 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Zhouyu DengBOCI Research Ltd.
Songtao YEChangjiang Securities Co. LTD.
Yichi ZhangChina International Capital Corporation Limited